Thus, both pharmacological and siRNA-mediated targeting of p110α results in a significant decrease in the phosphorylation of Ser585 in the GM-CSF and IL-3 βc receptor in primary human AML cells and the induction of cell death. Here, CSF2 is linked to acute myeloid leukemia.